GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.

The FTSE 250 business's stock jumped 4.7%, or 6.3p, to 141.8p as investors bet it could be next food delivery group to be ...

It forecasts that the repurchases - which are due to complete in 18 months - will boost core earnings by 6% to 8% in 2025 ...

Two former FTSE 100 stocks were in the spotlight today after Just Eat Takeaway.com backed a £3.4 billion takeover and B&M ...

(Alliance News) - Stock prices in London opened mostly flat on Monday, while across the channel Germany's election results have sparked uncertainty but also hopes of economic stimulus. The FTSE 100 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price ...

Last week’s full-year results from GlaxoSmithKline (GSK) do not answer every concern the sceptics may have regarding current ...